Efficacy of ustekinumab against infliximab-induced psoriasis and arthritis associated with Crohn’s disease
Satohiro Matsumoto, Hirosato Mashima Department of Gastroenterology, Saitama Medical Center, Jichi Medical University, Saitama, Japan Abstract: Anti-TNFα drugs have been shown to be effective for maintaining stable remission in patients with Crohn’s disease. However, some problem...
Enregistré dans:
Auteurs principaux: | Matsumoto S, Mashima H |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Dove Medical Press
2018
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/c95abb24c49043a797850f7a694777c1 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Clinical utility of ustekinumab in Crohn’s disease
par: Kotze PG, et autres
Publié: (2018) -
Secukinumab: Rapid Efficacy in Psoriasis After Primary Failure With Ustekinumab and Adalimumab
par: Aline Lissa Okita, et autres
Publié: (2020) -
Ustekinumab-induced chronic lymphocytic leukemia in a patient with psoriatic arthritis
par: Fusun Gediz, et autres
Publié: (2021) -
A Practical Guide to Therapeutic Drug Monitoring of Biologic Medications for Inflammatory Bowel Disease
par: Byron P. Vaughn
Publié: (2021) -
Machine learning gene expression predicting model for ustekinumab response in patients with Crohn's disease
par: Manrong He, et autres
Publié: (2021)